MeiraGTx/$MGTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MeiraGTx
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Ticker
$MGTX
Sector
Primary listing
Employees
409
Headquarters
Website
MeiraGTx Metrics
BasicAdvanced
$856m
-
-$1.49
1.24
-
Price and volume
Market cap
$856m
Beta
1.24
52-week high
$11.85
52-week low
$5.02
Average daily volume
943k
Financial strength
Current ratio
0.546
Quick ratio
0.508
Long term debt to equity
-103.917
Total debt to equity
-150.581
Interest coverage (TTM)
-8.76%
Profitability
EBITDA (TTM)
-92.72
Gross margin (TTM)
95.41%
Net profit margin (TTM)
-151.12%
Operating margin (TTM)
-131.89%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
-28.06%
Return on equity (TTM)
963.07%
Valuation
Price to revenue (TTM)
9.384
Price to book
-12.95
Price to tangible book (TTM)
-12.84
Price to free cash flow (TTM)
214.142
Free cash flow yield (TTM)
0.47%
Free cash flow per share (TTM)
0.043
Growth
Revenue change (TTM)
131.13%
Earnings per share change (TTM)
-34.58%
3-year revenue growth (CAGR)
80.24%
3-year earnings per share growth (CAGR)
-18.90%
What the Analysts think about MeiraGTx
Analyst ratings (Buy, Hold, Sell) for MeiraGTx stock.
MeiraGTx Financial Performance
Revenues and expenses
MeiraGTx Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs